MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jac/dkae037

Медицинская библиотека · The Journal of antimicrobial chemotherapy · 2024

Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring.

Mikulska Malgorzata, Melchio Monica, Signori Alessio, Ullah Nadir, Miletich Franca, Sepulcri Chiara, Limongelli Alessandro, Giacobbe Daniele Roberto, Balletto Elisa, Russo Chiara, Magnasco Laura, Vena Antonio, Di Grazia Carmen, Raiola Anna Maria, Portunato Federica, Dentone Chiara, Battaglini Denise, Ball Lorenzo, Robba Chiara, Angelucci Emanuele, Brunetti Iole, Bassetti Matteo

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Isavuconazole is first-line treatment of invasive aspergillosis. Therapeutic drug monitoring (TDM) is deemed not necessary, since most patients reached therapeutic levels (>1 mg/L) in large studies. Low levels were reported in some critically ill patients admitted to the ICU. The aim was to compare isavuconazole levels between critically ill and non-critically ill patients.

MATERIALS AND

METHODS

Retrospective analysis of data from all patients treated with standard-dose isavuconazole between 1 January 2019 and 26 October 2022 was performed. The following data were collected: TDM results from the first 30 days of therapy; ward of admission; demographic and clinical characteristics; continuous renal replacement therapy; extracorporeal membrane oxygenation; and co-administered drugs.

RESULTS

Seventy-two patients (median age 65 years) and 188 TDM measurements (mean number of samples per patient 2.6 ± 1.7) were included; 33 (45.8%) were ICU patients (3 also had haematological disorders); 39 (54.2%) were non-ICU patients, of whom 31 had haematological disorders. In all patients, the mean isavuconazole blood level was 3.33 ± 2.26 mg/L. Significantly lower levels were observed in the ICU versus the non-ICU population: mean 2.02 ± 1.22 versus 4.15 ± 2.31 mg/L (P < 0.001). Significantly higher rates of subtherapeutic levels were observed in ICU patients compared with the non-ICU population: all determinations <2 mg/L in 33.3% versus 7.7%, and all determinations <1 mg/L in 12.1% versus 0%, respectively. Predictors of lower isavuconazole levels were admission to the ICU, BMI > 25 kg/m2, bilirubin > 1.2 mg/dL and the absence of haematological disorder.

CONCLUSIONS

ICU patients had significantly lower isavuconazole blood levels compared to non-ICU population. The TDM of isavuconazole for efficacy should be performed in ICU.

Для цитирования: Mikulska Malgorzata, Melchio Monica, Signori Alessio, Ullah Nadir, Miletich Franca, Sepulcri Chiara, Limongelli Alessandro, Giacobbe Daniele Roberto, Balletto Elisa, Russo Chiara, Magnasco Laura, Vena Antonio, Di Grazia Carmen, Raiola Anna Maria, Portunato Federica, Dentone Chiara, Battaglini Denise, Ball Lorenzo, Robba Chiara, Angelucci Emanuele, Brunetti Iole, Bassetti Matteo. Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring.. The Journal of antimicrobial chemotherapy. 2024. DOI: 10.1093/jac/dkae037.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.